Hints and tips:
...The deal will allow junk-rated Telecom Italia to cut its debt from the current €26bn to €14bn and has prompted rating agencies Fitch, S&P and Moody’s to place the group in review for a rating upgrade this...
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
...These days, Lilly is the world’s most valuable drugmaker, after overtaking Johnson & Johnson last summer. Its $610bn market capitalisation makes it the ninth biggest company on the S&P 500....
...Citi expects Nvidia and Eli Lilly alone will make up a quarter of S&P 500 earnings growth in 2024. How’s everyone feeling about this rally? Email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...A once-popular fund, the SPDR S&P Biotech ETF, has lost 14 per cent of its value this year, falling 60 per cent from its highs....
...There’s still a very narrow market leadership on full display.” The S&P 500 is up 4 per cent year to date....
...Investors are excited by ARD-101, a so-called TAS2R agonist, because it does not just activate GLP-1, the gut hormone used in popular weight-loss drugs from Novo Nordisk and Eli Lilly, but it also harnesses...
...Data from S&P Global indicated that a fifth of the company’s stock — totalling €930mn — is being targeted by short sellers, who typically borrow shares in order to sell them, buying them back later to profit...
...That view was echoed by Tricia Bryan, a WeightWatchers member who has lost 17lbs since pairing the Core programme with a Clinic prescription for Eli Lilly’s Zepbound. “The medication is a tool....
...Drugs made by Japan’s Eisai and Eli Lilly of the US have shown promise when used early in an individual’s development of the disease....
...P Global construction PMI data Results: Alfa-Laval Q4, Amgen Q4, BP Q4, Eli Lilly Q4, Ford Q4, H&R Block Q2, Gartner Q4, Infineon Technologies Q1, Linde Q4, Mitsubishi Q3, Nintendo Q3, Omnicom Q4, Prudential...
...Eli Lilly and chipmaker Broadcom)....
...Lilly & Co Q3, Ferrari Q3, Fox Q1, Hugo Boss Q3, Hyatt Hotels Q3, Starbucks Q4, Shopify Q3, S&P Global Q3, Papa John’s Q3, GoDaddy Q3, Moderna Q3, Marriott International Q3, Prudential Financial Q3, Tata...
...Stocks look a little nervous The S&P 500 peaked on July 31, and has fallen about 7 per cent since....
...It’s no coincidence that the S&P 500 is also having a stellar run....
...Here’s why S&P is making the U-turn....
...The company subsequently grew by acquiring other companies and counts Platts, part of credit rating company S&P, among its competitors....
...That compares with 0.2 per cent for the Stoxx 600 ex-UK and 0.7 per cent for the S&P 500. AJ Bell has revealed that cash accounts for 13.3 per cent of its retail customer assets....
...Companies on the S&P 500 index are expected to report a 6.8 per cent decline in first-quarter earnings, Eli Lilly’s CEO told the Financial Times that Europe may miss out on new drugs if it pushes ahead with...
...The company’s biggest competitor in the market, Indianapolis-based Eli Lilly, has applied for regulatory approval to use its diabetes drug Mounjaro to treat obesity....
...Results: Apple, Eli Lilly, ConocoPhillips, Fox, Starbucks, S&P Global, Moderna, Shopify and Paramount Global will report before the market opens....
...Frank Gill, sovereign specialist for Europe, Middle East and Africa at S&P Global Ratings, said he expected European countries to step up their issuance of bonds targeted at retail investors....
...The first two drugs shown in clinical trials to slow the progression of the disease — donanemab from Eli Lilly of the US and lecanemab developed by Japan’s Eisai with US biotech Biogen — reduce the build-up...
...The S&P 500 and the Euro Stoxx 600 indices are up about a quarter since the start of October....
...He was actually born in Argentina, where his father was running the Latin America division for pharmaceuticals company Eli Lilly....
International Edition